Clascoterone: First Approval.
- Published in:
- Drugs, 2020, v. 80, n. 16, p. 1745, doi. 10.1007/s40265-020-01417-6
- By:
- Publication type:
- Article
Works matching IS 00126667 AND DT 2020 AND VI 80 AND IP 16
Results: 10
1
2
Oliceridine: First Approval.
- Published in:
- Drugs, 2020, v. 80, n. 16, p. 1739, doi. 10.1007/s40265-020-01414-9
- By:
- Publication type:
- Article
3
Trastuzumab Emtansine: A Review of Its Adjuvant Use in Residual Invasive HER2-Positive Early Breast Cancer.
- Published in:
- Drugs, 2020, v. 80, n. 16, p. 1723, doi. 10.1007/s40265-020-01408-7
- By:
- Publication type:
- Article
4
Tafasitamab: First Approval.
- Published in:
- Drugs, 2020, v. 80, n. 16, p. 1731, doi. 10.1007/s40265-020-01405-w
- By:
- Publication type:
- Article
5
Targeting the PI3K/AKT/mTOR Pathway in Hormone-Positive Breast Cancer.
- Published in:
- Drugs, 2020, v. 80, n. 16, p. 1685, doi. 10.1007/s40265-020-01394-w
- By:
- Publication type:
- Article
6
Targeted Therapy for Chronıc Spontaneous Urtıcarıa: Ratıonale and Recent Progress.
- Published in:
- Drugs, 2020, v. 80, n. 16, p. 1617, doi. 10.1007/s40265-020-01387-9
- By:
- Publication type:
- Article
7
HIV-1 Integrase Inhibitors: A Comparative Review of Efficacy and Safety.
- Published in:
- Drugs, 2020, v. 80, n. 16, p. 1649, doi. 10.1007/s40265-020-01379-9
- By:
- Publication type:
- Article
8
Post-Thoracotomy Pain: Current Strategies for Prevention and Treatment.
- Published in:
- Drugs, 2020, v. 80, n. 16, p. 1677, doi. 10.1007/s40265-020-01390-0
- By:
- Publication type:
- Article
9
Intrauterine Exposure to Biologics in Inflammatory Autoimmune Diseases: A Systematic Review.
- Published in:
- Drugs, 2020, v. 80, n. 16, p. 1699, doi. 10.1007/s40265-020-01376-y
- By:
- Publication type:
- Article
10
Pharmacological Approaches to Managing Violence and Aggression in Prison Populations: Clinical and Ethical Issues.
- Published in:
- Drugs, 2020, v. 80, n. 16, p. 1635, doi. 10.1007/s40265-020-01372-2
- By:
- Publication type:
- Article